7th Sharkia Endocrinology & Diabetes Conference

The 7th Sharkia Endocrinology & Diabetes Conference serves as a flagship regional medical congress dedicated to advancing scientific knowledge, clinical decision-making, and multi-specialty therapeutic paradigms across endocrinology, diabetology, and metabolic healthcare. Organized in official collaboration with the Sharkia Medical Syndicate and Pure Spot Events Management, this milestone single-day conference is scheduled to take place on Thursday, November 19, 2026, at the Police Club in Zagazig, Egypt. Serving as a key educational and networking platform for healthcare professionals throughout the Nile Delta region, the gathering convenes academic leaders, university professors, consultant endocrinologists, diabetologists, internal medicine specialists, and primary care physicians to analyze evolving standard-of-care guidelines and translational clinical research. The intensive scientific curriculum provides a comprehensive, multi-faceted learning experience delivered through state-of-the-art lectures, evidence-based clinical symposia, and interactive case presentations. Primary clinical focus areas center on modern diagnostic and management protocols for both type 1 and type 2 diabetes mellitus. Key sessions explore novel pharmacological options—including SGLT2 inhibitors, GLP-1 receptor agonists, and dual incretin therapies—with a strong emphasis on cardiorenal protection and early glycemic control. Delegates will also review cutting-edge diabetes technologies, such as continuous glucose monitoring (CGM) systems, automated insulin delivery devices, and digital health tools for improved patient compliance. Beyond glycemic management, the conference curriculum thoroughly examines the diagnosis and treatment of complex endocrine pathologies. Specialized scientific modules focus on thyroid disorders, including nodule risk stratification, fine-needle aspiration biopsy interpretation, and modern approaches to thyroid carcinoma and autoimmune thyroid diseases. Additional panels address pituitary-adrenal axis dysfunctions, calcium and bone metabolic disorders, osteoporosis management, dyslipidemia, gestational diabetes, and metabolic dysfunction-associated steatotic liver disease (MASLD). By facilitating rigorous scientific dialogue, evaluating practical clinical challenges, and promoting interdisciplinary care, the 7th Sharkia Endocrinology & Diabetes Conference elevates standard medical practice and improves long-term outcomes for patients with endocrine and metabolic disorders across Egypt.